Navigation Links
UVIDEM in Medical News

IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives

IRVINE, Calif., Dec. 31 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that as part of the Company's recent decision to evaluate strategic alternatives, the Company initiated discussions with sanofi-aventis. Following this, sanofi-aventis has notified the Company o...

IDM Pharma Reports First Quarter Financial Results

...ollaboration agreement with sanofi-aventis for the uvidem program. As a result of sanofi-aventis' decision to terminate its participation in the uvidem development program in December 2007, no further such revenues related to uvidem were recognized after the first quarter of 2008. ...

IDM Pharma Reports First Quarter Financial Results

... a result of sanofi-aventis' decision to terminate its participation in the uvidem development program in December 2007, no further such revenues related to uvidem will be recognized after this quarter. Research and development (R&D) exp...

IDM Pharma Reports 2007 Financial Results

...ult of the decision by sanofi-aventis to terminate its participation in the uvidem development program in December 2007. Cash and cash equivalents was $28.4 m...fi-aventis' decision in December 2007 to terminate its participation in the uvidem development program. Interest income increased to $0.4 million for the th...

IDM Pharma Reports Third Quarter 2007 Financial Results

...due to an increase in development costs related to uvidem clinical trials, which are reimbursed by sanofi-av...due to an increase in development costs related to uvidem clinical trials, which are reimbursed by sanofi-av...6. The spending related to clinical development of uvidem and clinical development, regulatory filings and m...

IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial

... IDM Pharma, Inc. today presented preliminary results from a Phase II uvidem (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). The results showed that uvidem was well tolerated with evidence of efficacy and induction of immune respon...
UVIDEM in Medical Technology

IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company

...Updates UVIDEM(R) The next planned step in the uvidem development program is a Phase 2, open-label, randomized study of uvidem designed to evaluate patients with in-transient or...elanoma in the next 60 days. Patients will receive uvidem or...

IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients

...ated results showed that the investigational agent uvidem showed evidence of clinical activity and induction...recognized antigens after vaccination with uvidem were gp100 and MAGE. -- uvidem was well tolerated with only one possibly related ...

IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting

...annual meeting in Chicago on June 1-5 2007. uvidem presentation details: -- "Clinical and immu...gned to assess the safety and clinical activity of uvidem in patients with stage III or IV melanoma with mea...atient enrolled in March 2006. About UVIDEM(R) uvidem is a therapeutic specific immunostimulant develope...

IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial

... - Results show uvidem was well-tolerated with signs of durable disease c...inical trial (DC-MEL-202). The results showed that uvidem was well tolerated with evidence of efficacy and i...arance of anti-TAA specific CD8+ T cells. -- uvidem was well tolerated with toxicity limited to mild e...
UVIDEM in Biological Technology

IDM Pharma Reports 2008 Financial Results

...is' decision to terminate its participation in the uvidem development program in December 2007, we will not ... reduction in spending on MEPACT (mifamurtide) and uvidem development, as well as reductions associated with...ecember 2007 to terminate its participation in the uvidem development program. The $3.5 million includes $3...

IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development

...ical experience to IDM Pharma and will lead the regulatory and clinical strategy for L-MTP-PE and the development of the Company's pipeline, including uvidem and IDM-2101. He joins IDM Pharma from Takeda Global Research & Development Center, Inc., a subsidiary of Takeda Pharmaceutical Company Limited, where...
Other Tags
(Date:4/20/2015)... Genuine fat loss results can seem virtually ... in the past. But what failed dieters and gym-goers don’t ... guaranteed by adhering to five simple principles. , 1. Nutrition, ... many hours one spends working at the gym, a poor ... a nutritional mean plan does not mean starvation, calorie counting ...
(Date:4/20/2015)... 20, 2015 Today the members ... Research Fund-Ovarian Cancer National Alliance-National Ovarian Cancer Coalition ... Team will focus on “DNA Repair Therapies for ... identified DNA repair as a common weakness in ... and early detection of ovarian cancer by developing ...
(Date:4/20/2015)... Westchester County, New York (PRWEB) April 20, 2015 ... that the Centers for Medicare & Medicaid Services introduced ... of their HCAHPS (Hospital Consumer Assessment of Healthcare Providers ... This national survey asks patients about their experiences during ... current survey results from July 1, 2013 through June ...
(Date:4/20/2015)... The buttocks tend to become sore and ... from Longmont, Colo., decided that there needed to be ... use, compact and ideal for travelers and truck drivers, ... from becoming sore during travel via airplanes and vehicles. ... blood circulation, which helps to avoid blood clots. , ...
(Date:4/20/2015)... Columbia (PRWEB) April 20, 2015 Cannabix ... a hand-held Cannabix Marijuana Breathalyzer for law enforcement and ... the first publicly available images of its marijuana breathalyzer ... Cannabix Marijuana Breathalyzer. Media files and video that show ... for online viewing at cannabixtechnologies.com . , The ...
Breaking Medicine News(10 mins):Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3Health News:Cannabix Technologies Inc. Releases New Images of Marijuana Breathalyzer Prototype 2Health News:Cannabix Technologies Inc. Releases New Images of Marijuana Breathalyzer Prototype 3Health News:Cannabix Technologies Inc. Releases New Images of Marijuana Breathalyzer Prototype 4
(Date:4/1/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces the second shipment of ... to early access pre-order customers. Feedback ... outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop & ... at all outlets and very easy to use. Several ...
(Date:3/31/2015)... YORK , March 31, 2015  Elephant Talk ... "Company"), a global provider of Software Defined Network Architecture ... today announced total revenue of approximately $20.4 million for ... a restated $19.5 million for the year ended December ... calendar 2014, the Company had completed its multi-year transition ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
Other Contents